The Original SAMe 400 mg
Natural health product licensed in Canada
- Licence holder
- Nutralife Health Products
- NPN or DIN-HM
- 80072162
- Status
- Active licence
- Licence date
- 22 August 2016
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Acide stéarique, Gomme de cellulose, Oxyde de fer jaune, Copolymère d'acide méthacrylique, Silice, Acide citrique, Glycolate d'amidon sodique, Cellulose, Phtalate d'hypromellose, Dioxyde de titane, D-Mannitol, Triacétine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Helps relieve pain due to osteoarthritis. Helps to support a healthy mood balance. Helps support healthy liver function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Product may cause anxiety, restlessness and/or insomnia.
- Contre-indications
Do not use if you have bipolar disorder or manic depression. If you are taking antidepressants, hepatotoxic drugs, or MAOIs, consult a physician before using this product. Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
May cause mild gastrointestinal upset. Do not take at night since product may cause anxiety, restlessness and/or insomnia. For pain due to osteoarthritis: If symptoms persist or worsen, consult a health care practitioner.
Source
Official Health Canada record, licence 80072162
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.